These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19485910)

  • 1. Cardiovascular effects of endogenous estrogen and hormone therapy.
    Bechlioulis A; Naka KK; Calis KA; Makrigiannakis A; Michalis L; Kalantaridou SN
    Curr Vasc Pharmacol; 2010 Mar; 8(2):249-58. PubMed ID: 19485910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Postmenopausal hormone replacement therapy and the cardiovascular system].
    Yildirir A
    Turk Kardiyol Dern Ars; 2010 Mar; 38 Suppl 1():32-40. PubMed ID: 21491714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy and the cardiovascular system lessons learned and unanswered questions.
    Ouyang P; Michos ED; Karas RH
    J Am Coll Cardiol; 2006 May; 47(9):1741-53. PubMed ID: 16682298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression.
    Clarkson TB
    Menopause; 2018 Nov; 25(11):1262-1274. PubMed ID: 30358722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Need for research on estrogen receptor function: importance for postmenopausal hormone therapy and atherosclerosis.
    Meyer MR; Haas E; Barton M
    Gend Med; 2008; 5 Suppl A():S19-33. PubMed ID: 18395680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The menopause: benefits and risks of estrogen-progestogen replacement therapy.
    Gambrell RD
    Fertil Steril; 1982 Apr; 37(4):457-74. PubMed ID: 7040116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence.
    Harman SM; Naftolin F; Brinton EA; Judelson DR
    Ann N Y Acad Sci; 2005 Jun; 1052():43-56. PubMed ID: 16024750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiovascular disease as a current threat of older women. Relation to estrogens].
    Zárate A; Saucedo R; Basurto L; Martínez C
    Ginecol Obstet Mex; 2007 May; 75(5):286-92. PubMed ID: 17849811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KEEPS: The Kronos Early Estrogen Prevention Study.
    Harman SM; Brinton EA; Cedars M; Lobo R; Manson JE; Merriam GR; Miller VM; Naftolin F; Santoro N
    Climacteric; 2005 Mar; 8(1):3-12. PubMed ID: 15804727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oestrogens and the heart.
    Rosano GM; Panina G
    Therapie; 1999; 54(3):381-5. PubMed ID: 10500455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gaps, limitations and new insights on endogenous estrogen and follicle stimulating hormone as related to risk of cardiovascular disease in women traversing the menopause: A narrative review.
    El Khoudary SR
    Maturitas; 2017 Oct; 104():44-53. PubMed ID: 28923176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogens, lipoproteins, and cardiovascular risk factors: an update following the randomized placebo-controlled trials of hormone-replacement therapy.
    Seed M; Knopp RH
    Curr Opin Lipidol; 2004 Aug; 15(4):459-67. PubMed ID: 15243220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol and atherosclerosis: modulation by oestrogen.
    Barton M
    Curr Opin Lipidol; 2013 Jun; 24(3):214-20. PubMed ID: 23594711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone replacement therapy and cardioprotection: the end of the tale?
    Rosano GM; Vitale C; Silvestri A; Fini M
    Ann N Y Acad Sci; 2003 Nov; 997():351-7. PubMed ID: 14644842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormones and cardiovascular health in women.
    ESHRE Capri Workshop Group
    Hum Reprod Update; 2006; 12(5):483-97. PubMed ID: 16807276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone therapy for preventing cardiovascular disease in post-menopausal women.
    Boardman HM; Hartley L; Eisinga A; Main C; Roqué i Figuls M; Bonfill Cosp X; Gabriel Sanchez R; Knight B
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD002229. PubMed ID: 25754617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of cardiovascular age for assessing risks and benefits of menopausal hormone therapy.
    Santen RJ
    Menopause; 2017 May; 24(5):589-595. PubMed ID: 28323768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular health in the menopausal woman: impact of the timing of hormone replacement therapy.
    Rosano G; Vitale C; Spoletini I; Fini M
    Climacteric; 2012 Aug; 15(4):299-305. PubMed ID: 22424090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
    Koledova VV; Khalil RA
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.